Subsequently, recruited MDSCs produce immunosuppressive components such as reactive oxygen species (ROS) and arginase 1 to suppress CD8+ T cells and NK cells in breast cancer pre-metastatic niches (PMNs) (Wang et al., 2019). The gene discussed is CD8A; the disease is breast carcinoma.